ArticleFrontiers in oral health2025
Exploring the interplay of vitamin D, salivary antimicrobial peptides, and cytokines in oral immunity and disease prevention: an insight for implications in oral health policy.
Article in Frontiers in oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Oral diseases such as caries and periodontitis are complex, multifactorial diseases and remain the most prevalent worldwide. Both diseases are associated with vitamin D deficiency (VDD) and its pathophysiological process. The prevalence of metabolic syndrome (MetS) is rising in developing countries, and studies have shown that oral diseases are more prevalent among the metabolic group. This study aims to assess and correlate the relationship between serum vitamin D levels, salivary antimicrobial peptides (AMPs), and their role in oral health. Materials and methods: A total of 80 individuals aged 35-75 years were recruited, including 40 patients in the metabolic syndrome group, following the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria, and 40 in the non-metabolic group. Serum vitamin D levels and salivary AMPs were estimated using enzyme-linked immunosorbent assay (ELISA). Oral health status was assessed using the Decayed, Missing, Filled Teeth (DMFT) index and by recording the presence or absence of periodontal pockets. The data obtained were subjected to statistical analysis to determine correlations between systemic status, biochemical markers, and oral health parameters. Results: The Mann-Whitney Conclusions: Within the study's limitations, a potential link between metabolic syndrome and compromised oral health was observed, as demonstrated by increased caries incidence and periodontal involvement. While variations in serum vitamin D and salivary AMPs did not achieve statistical significance, the findings suggest an altered host defense mechanism in metabolic syndrome patients. Larger, longitudinal studies are required to further elucidate these associations and emphasize the importance of routine oral screening in individuals with metabolic disorders, and the implementation of oral health polices is mandatory to maintain good oral health and well-being among both metabolic and non-metabolic populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.